Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Therapeutic Clinical Trials Review, H2, 2018

GlobalData
49 Pages - GLDATA66201
$2,500.00

Summary

GlobalData's clinical trial report, “Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2018" provides an overview of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Urticaria Pigmentosa (Mastocytosis, Mastocytoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Companies Mentioned
AB Science SA
C. H. Boehringer Sohn AG & Co KG
Novartis AG
Alpha Bioresearch SL
NicOx SA
Merck & Co Inc
Maya Clinicals Inc
JADO Technologies GmbH
GlaxoSmithKline Plc
Chongqing Winbond Pharmaceutical Co Ltd

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 47
Abbreviations 47
Definitions 47
Research Methodology 48
Secondary Research 48
About GlobalData 48
Contact Us 49
Source 49

List of Tables
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, G7 Countries (%), 2018* 16
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, E7 Countries (%), 2018* 20
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31

List of Figures
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, G7 Countries (%), 2018* 15
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, E7 Countries (%), 2018* 19
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31
GlobalData Methodology 48

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports